ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08474
-0,01%
Bitcoin
68.515,23
0,01%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Protect Pharmaceutical Corporation (PK) (PRTT)

  7. Protect Pharmaceutical Corporation (PK) (PRTT) News

PRTT

Protect Pharmaceutical (PK) (PRTT)

Protect Pharmaceutical Corporation (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:PRTT
DatumZeitQuelleÜberschriftSymbolFirma
25/09/202014h30InvestorsHub NewsWireProtect Pharmaceuticals Shares Could Soar As Merger Date Approaching SoonUSOTC:PRTTProtect Pharmaceutical Corporation (PK)
12/06/201912h11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
12/06/201912h11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
02/04/201918h12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
06/03/201921h56Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
01/03/201912h33Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
28/02/201915h24Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
21/02/201912h09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
19/02/201912h05Edgar (US Regulatory)Annual Report (10-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
08/02/201921h58Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
07/02/201920h51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
31/01/201916h54Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
10/12/201812h09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/11/201816h49Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
06/06/201815h20Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
05/06/201822h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/08/201722h57Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/07/201720h04MarketwiredStartCapital and Eight Dragons Company Form Contract on Corporate DevelopmentUSOTC:PRTTProtect Pharmaceutical Corporation (PK)
13/07/201717h41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
07/07/201717h29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
17/06/201704h54MarketwiredProtect Pharmaceuticals Corporation Changes Business ModelUSOTC:PRTTProtect Pharmaceutical Corporation (PK)
19/05/201719h52Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
15/05/201719h44Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
31/03/201719h28Edgar (US Regulatory)Annual Report (10-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
21/11/201620h40Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/11/201620h51Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
20/09/201618h22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
09/09/201622h31Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
15/08/201623h27Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
02/06/201621h05Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
 Showing the most relevant articles for your search:USOTC:PRTT

Kürzlich von Ihnen besucht

USOTC
BASFY
BASF (QX)
NASDAQ
AAPL
Apple
TG
BAYN
Bayer
TG
432
Arbor Metals
AMEX
SPY
SPDR S&P 500
TG
DBK
Deutsche Bank
COIN
BTCUSD
Bitcoin
DBI
SDXP
SDAX
TG
D7G
Nel ASA
NASDAQ
MSFT
Microsoft
TG
DTE
Deutsche Telekom
CCOM
SILVER
SILVER
NYSE
JPM
JP Morgan Chase
DBI
TDXP
Tec DAX
TG
LHA
Deutsche Lufthansa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten